Nanopore sequencing detects structural variants in cancer

Cancer Biology and Therapy

Volumn 17, Issue 3, 2016, Pages 246-253

  Norris, Alexis L ^a   Workman, Rachael E ^b   Fan, Yunfan ^b   Eshleman, James R ^a   Timp, Winston ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Johns Hopkins University   (United States)

Author keywords

3rd generation sequencing; cancer diagnostics; Deletions; DNA sequencing; inversions; nanopore sequencing; next generation sequencing; structural variation; translocations; tumor suppressor gene

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; PROTEIN P16; SMAD4 PROTEIN; SMAD4 PROTEIN, HUMAN;

AMPLICON; ARTICLE; ARTIFACT; CANCER DIAGNOSIS; CONTROLLED STUDY; COULTER COUNTER; DIAGNOSTIC ACCURACY; DNA DETERMINATION; DNA SEQUENCE; ELECTRIC CURRENT; FRAMESHIFT MUTATION; GENE DELETION; GENE TRANSLOCATION; HEALTH CARE COST; NANOPORE; NEXT GENERATION SEQUENCING; NUCLEIC ACID BASE SUBSTITUTION; TUMOR SUPPRESSOR GENE; DNA STRAND BREAKAGE; GENETICS; HUMAN; PANCREAS CARCINOMA; PANCREAS TUMOR; PROCEDURES;

CARCINOMA, PANCREATIC DUCTAL; DNA BREAKS; GENES, P16; GENES, TUMOR SUPPRESSOR; HUMANS; NANOPORES; PANCREATIC NEOPLASMS; SEQUENCE ANALYSIS, DNA; SMAD4 PROTEIN;

EID: 84959039248     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.1080/15384047.2016.1139236     Document Type: Article

References (27)

1. P.C.Nowell, D.A.Hungerford. Chromosome studies on normal and leukemic human leukocytes. J Natl Cancer Inst 1960; 25:85-109; PMID:14427847
2. T.P.Dryja, J.M.Rapaport, J.M.Joyce, R.A.Petersen. Molecular detection of deletions involving band q14 of chromosome 13 in retinoblastomas. Proc Natl Acad Sci U S A 1986; 83:7391-4; PMID:2876425; http://dx.doi.org/10.1073/pnas.83.19.7391
3. D.J.Slamon, G.M.Clark, S.G.Wong, W.J.Levin, A.Ullrich, W.L.McGuire. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235:177-82; PMID:3798106; http://dx.doi.org/10.1126/science.3798106
4. S.Jones, X.Zhang, D.W.Parsons, J.C.Lin, R.J.Leary, P.Angenendt, P.Mankoo, H.Carter, H.Kamiyama, A.Jimeno, et al. Core signaling pathways in human pancreatic cancers revealed by global genomic analyses. Science 2008; 321:1801-6; PMID:18772397; http://dx.doi.org/10.1126/science.1164368
5. A.V.Biankin, N.Waddell, K.S.Kassahn, M.C.Gingras, L.B.Muthuswamy, A.L.Johns, D.K.Miller, P.J.Wilson, A.M.Patch, J.Wu, et al. Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes. Nature 2012; 491:399-405; PMID:23103869; http://dx.doi.org/10.1038/nature11547
6. A.L.Norris, H.Kamiyama, A.Makohon-Moore, A.Pallavajjala, L.A.Morsberger, K.Lee, D.Batista, C.A.Iacobuzio-Donahue, M.T.Lin, A.P.Klein, et al. TransFlip mutations produce deletions in pancreatic cancer. Genes, Chromosomes Cancer 2015; (54)8:472-481; PMID:26031834; http://dx.doi.org/10.1002/gcc.22258
7. F.Diehl, K.Schmidt, M.A.Choti, K.Romans, S.Goodman, M.Li, K.Thornton, N.Agrawal, L.Sokoll, S.A.Szabo, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med 2008; 14:985-90; PMID:18670422; http://dx.doi.org/10.1038/nm.1789
8. C.Bettegowda, M.Sausen, R.J.Leary, I.Kinde, Y.Wang, N.Agrawal, B.R.Bartlett, H.Wang, B.Luber, R.M.Alani, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 2014; 6:224ra24; PMID:24553385; http://dx.doi.org/10.1126/scitranslmed.3007094
9. J.Tie, I.Kinde, Y.Wang, H.L.Wong, J.Roebert, M.Christie, M.Tacey, R.Wong, M.Singh, C.S.Karapetis, et al. Circulating Tumor DNA as an Early Marker of Therapeutic Response in Patients with Metastatic Colorectal Cancer. Ann Oncol 2015; PMID:25851626; http://dx.doi.org/10.1093/annonc/mdv177
10. A.F.A.Smit, R.Hubley, P.Green. RepeatMasker Open-4.0. http://www.repeatmasker.org: 2013.
11. A.Ritz, A.Bashir, S.Sindi, D.Hsu, I.Hajirasouliha, B.J.Raphael. Characterization of structural variants with single molecule and hybrid sequencing approaches. Bioinformatics 2014; 30:3458-66; PMID:25355789; http://dx.doi.org/10.1093/bioinformatics/btu714
12. G.Church, D.W.Deamer, D.Branton, R.Baldarelli, J.Kasianowicz, USPTO. Characterization of individual polymer molecules based on monomer-interface interactions. 1995;
13. W.Timp, A.M.Nice, E.M.Nelson, V.Kurz, K.McKelvey, G.Timp. Think Small: Nanopores for Sensing and Synthesis. IEEE Access 2014; 2:1396-408; http://dx.doi.org/10.1109/ACCESS.2014.2369506
14. A.C.Tsiatis, A.Norris-Kirby, R.G.Rich, M.J.Hafez, C.D.Gocke, J.R.Eshleman, K.M.Murphy. Comparison of Sanger sequencing, pyrosequencing, and melting curve analysis for the detection of KRAS mutations: diagnostic and clinical implications. J Mol Diagn 2010; 12:425-32; PMID:20431034; http://dx.doi.org/10.2353/jmoldx.2010.090188
15. J.R.Eshleman, S.D.Markowitz, P.S.Donover, E.Z.Lang, J.D.Lutterbaugh, G.M.Li, M.Longley, P.Modrich, M.L.Veigl, W.D.Sedwick. Diverse hypermutability of multiple expressed sequence motifs present in a cancer with microsatellite instability. Oncogene 1996; 12:1425-32; PMID:8622858
16. S.Markowitz, J.Wang, L.Myeroff, R.Parsons, L.Sun, J.Lutterbaugh, R.S.Fan, E.Zborowska, K.W.Kinzler, B.Vogelstein, et al. Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science 1995; 268:1336-8; PMID:7761852; http://dx.doi.org/10.1126/science.7761852
17. R.M.Layer, C.Chiang, A.R.Quinlan, I.M.Hall. LUMPY: a probabilistic framework for structural variant discovery. Gen Biol 2014; 15:R84; PMID:24970577; http://dx.doi.org/10.1186/gb-2014-15-6-r84
18. A.C.English, W.J.Salerno, O.A.Hampton, C.Gonzaga-Jauregui, S.Ambreth, D.I.Ritter, C.R.Beck, C.F.Davis, M.Dahdouli, S.Ma, et al. Assessing structural variation in a personal genome-towards a human reference diploid genome. BMC Gen 2015; 16:286; PMID:25886820; http://dx.doi.org/10.1186/s12864-015-1479-3
19. M.-T.Lin, S.L.Mosier, M.Thiess, K.F.Beierl, M.Debeljak, L.-H.Tseng, G.Chen, S.Yegnasubramanian, H.Ho, L.Cope, et al. Clinical Validation of KRAS, BRAF, and EGFR Mutation Detection Using Next-Generation Sequencing. Am J Clin Pathol 2014; 141:856-66; PMID:24838331; http://dx.doi.org/10.1309/AJCPMWGWGO34EGOD
20. N.J.Loman, J.Quick, J.T.Simpson. A complete bacterial genome assembled de novo using only nanopore sequencing data. Nat Meth 2015; 12:733-5; PMID:26076426; http://dx.doi.org/10.1038/nmeth.3444
21. I.Sovic, M.Sikic, A.Wilm, S.N.Fenlon, S.Chen, N.Nagarajan. Fast and sensitive mapping of error-prone nanopore sequencing reads with GraphMap. bioRxiv 2015:020719.
22. H.Li. Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM. arXiv preprint arXiv:13033997 2013;
23. S.Goodwin, J.Gurtowski, S.Ethe-Sayers, P.Deshpande, M.Schatz, W.R.McCombie. Oxford Nanopore sequencing, hybrid error correction, and de novo assembly of a eukaryotic genome. Genome Res 2015; 25:1750–6; PMID: 26447147; http://dx.doi.org/10.1101/gr.191395.115
24. C.L.C.Ip, M.Loose, J.R.Tyson, M.de Cesare, B.L.Brown, M.Jain, R.M.Leggett, D.A.Eccles, V.Zalunin, J.M.Urban, et al. MinION Analysis and Reference Consortium: Phase 1 data release and analysis. F1000Research [Internet] 2015 [cited 2015 Dec 8]; Available from:http://f1000research.com/articles/4-1075/v1
25. A.L.Norris, N.J.Roberts, S.Jones, S.J.Wheelan, N.Papadopoulos, B.Vogelstein, K.W.Kinzler, R.H.Hruban, A.P.Klein, J.R.Eshleman. Familial and sporadic pancreatic cancer share the same molecular pathogenesis. Fam Cancer 2015; 14:95-103; PMID:25240578; http://dx.doi.org/10.1007/s10689-014-9755-y
26. A.Untergasser, I.Cutcutache, T.Koressaar, J.Ye, B.C.Faircloth, M.Remm, S.G.Rozen. Primer3—new capabilities and interfaces. Nucl Acid Res 2012; 40:e115-e115; PMID:22730293; http://dx.doi.org/10.1093/nar/gks596
27. W.Timp, J.Comer, A.Aksimentiev. DNA base-calling from a nanopore using a Viterbi algorithm. Biophys J 2012; 102:L37-9; PMID:22677395; http://dx.doi.org/10.1016/j.bpj.2012.04.009